Borderline Personality Disorder: Updates on Treatment
Borderline personality disorder (BPD) is a psychiatric condition characterized by emotional instability, impulsivity, self-destructive behaviour and dysfunctional interpersonal relationship patterns. With a high prevalence in clinical settings, BPD is often associated with comorbidities such as depression, anxiety disorders and substance use. This literature review aims to analyze the most recent updates on the clinical management of the disorder, with an emphasis on psychotherapeutic interventions and limiting the use of pharmacotherapy. The evidence shows that psychotherapy remains the first-line treatment, with emphasis on approaches such as dialectical behaviour therapy (DBT), mentalization-based therapy (MBT), schema therapy and transference-focused psychotherapy (TFP). On the other hand, the use of psychotropic drugs remains controversial and should be restricted to severe comorbid symptoms. New perspectives include the development of digital therapies, early interventions and personalized treatments. The study reinforces the need to expand access to evidence-based therapies, train professionals and combat the stigma that still surrounds
Borderline Personality Disorder: Updates on Treatment
-
DOI: https://doi.org/10.22533/at.ed.15952625140714
-
Palavras-chave: ---
-
Keywords: ----
-
Abstract:
Borderline personality disorder (BPD) is a psychiatric condition characterized by emotional instability, impulsivity, self-destructive behaviour and dysfunctional interpersonal relationship patterns. With a high prevalence in clinical settings, BPD is often associated with comorbidities such as depression, anxiety disorders and substance use. This literature review aims to analyze the most recent updates on the clinical management of the disorder, with an emphasis on psychotherapeutic interventions and limiting the use of pharmacotherapy. The evidence shows that psychotherapy remains the first-line treatment, with emphasis on approaches such as dialectical behaviour therapy (DBT), mentalization-based therapy (MBT), schema therapy and transference-focused psychotherapy (TFP). On the other hand, the use of psychotropic drugs remains controversial and should be restricted to severe comorbid symptoms. New perspectives include the development of digital therapies, early interventions and personalized treatments. The study reinforces the need to expand access to evidence-based therapies, train professionals and combat the stigma that still surrounds
- RYAN RAFAEL BARROS DE MACEDO
- JOSÉ MICAEL DELGADO BARBOSA
- CAMILA FARINA RIGO
- JÓICE CAROLINA MONTEIRO JUCOSKI
- LARISSA TRINDADE SILVA GARCIA
- CARLOS ANDRÉ RODRIGUES BINDA
- TATIANA DA SILVA RASCADO
- CLAUDEBAN BENTO ALVES
- FERNANDO MALACHIAS DE ANDRADE BERGAMO
- GABRIEL ARAÚJO FERRARI FIGUEIREDO
- NICOLAS MADEIRA FLORES
- HELOISA RIBEIRO BORGES
- GUILHERME AUGUSTO DA MATA ROSAS